News Daily News Sapien 3 Approved for Use in Intermediate-Risk Patients in Europe Michael O'Riordan September 20, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for August 2016 Caitlin E. Cox September 01, 2016
News Daily News TAVR as an Option for Intermediate-Risk Patients: Physicians Respond Yael L. Maxwell August 24, 2016
News Daily News FDA Approves Sapien XT and Sapien 3 for Intermediate-Risk Patients Yael L. Maxwell August 18, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2016 Shelley Wood April 29, 2016